Whether you are a radiation oncologist or a dermatologist, you can enhance your patient care with the SRT-100™ non-melanoma skin cancer treatment.
SRT-100™: A Non-Melanoma Skin Cancer Treatment Your Body Can Handle, but Cancer Cannot
Skin cancer is the fastest growing cancer in the world. Experts predict the number of people diagnosed with non-melanoma skin cancer will grow to nearly six million by the year 2020. With the epidemic of basal and squamous cell skin cancer diagnosis follows the common and less than ideal solution of surgical non-melanoma skin cancer […]
Sensus Healthcare, Inc. Receives the Frost & Sullivan 2016 Global Non-melanoma Skin Cancer Therapy Technology Leadership Award
– Sensus Credited with Advancing Superficial Radio Therapy as Viable Treatment Option for NMSC – BOCA RATON, Fla., Sept. 7, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions such as keloids with superficial radiation therapy (SRT), announced today it […]
Sensus Healthcare to Sponsor First International Keloid Symposium on September 8 and 9 in New York
BOCA RATON, Fla., Aug. 31, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy (SRT), today announced that the Company will sponsor the First International Keloid Symposium to be held at The Rockefeller University […]
Ask Your Doctor About the SRT-100™ to Treat Your Basal Cell Carcinoma
Have you been diagnosed with skin cancer? You are not alone. Skin cancer is one of the most commonly occurring forms of cancer, with more than one in every three new cancers diagnosed as skin cancer. Basal cell carcinoma is one type of skin cancer and occurs more frequently than any other form of skin […]
Treat Your Patients’ Basal Cell Carcinoma with the Revolutionary SRT-100™
Any dermatologist knows just how devastating a skin cancer diagnosis can be to his or her patients. Skin cancer is diagnosed nearly three times as often as any other form of cancer, with the most common of all skin cancers being basal cell carcinoma. While patients facing basal cell carcinoma have multiple choices available for […]
Hear What Patients and Physicians Have to Say About the SRT-100™ for Keloid Treatment
Patients and physicians both are talking about revolutionary keloid treatment offered by the SRT-100™. Hear what they have to say. :
Sensus Healthcare Reports Second Quarter 2016 Results
– Q2 revenues increased 49% year-over-year to $3.6 million – Worldwide installed base increased to 247 units -Successfully completed IPO on June 2nd; cash of $15.8 million, with no debt, at June 30, 2016 BOCA RATON, Fla., Aug. 4, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of […]
Mike Masterson: Arkansas Approves Zapping Cancers
By Mike Masterson Posted: August 2, 2016 at 5:45 a.m. Editor’s note: The original version of the column was published March 9, 2014. There the thing still was, frowning from the mirror. That crusty red spot on the very tip of my nose wasn’t going away despite weeks of salves. It appeared to be steadily […]
Sensus Healthcare to Announce Second Quarter 2016 Results on August 4, 2016
BOCA RATON, Fla., Aug. 2, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS; SRTSW), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today provided a reminder that it will report its second quarter 2016 financial results on Thursday, August 4, 2016 […]
Sensus Healthcare, Inc. Names Anthony Petrelli to its Board of Directors
– Over 40 Years in Investment Banking – Extensive Regulatory and Securities Advisory Experience BOCA RATON, Fla., Aug. 2, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced the appointment of Anthony […]
New Procedure Spares Skin Cancer Patients From Surgery
Colorado’s Attorney General Cynthia Coffman became among the first in the state to undergo treatment with the SRT-100™. Doctor Kevin Schewe at Red Rocks Radiation Center, in partnership with Presbyterian/St. Luke’s Medical Center and Sarah Cannon Research Institute, is the only one in Colorado offering Superficial Radio Therapy with the SRT-100™ for patients with non-melanoma […]
Sensus Healthcare, Inc. Units Separate; Trading of Common Stock and Warrants Commences
BOCA RATON, Fla., July 25, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today reported the separation of the 2,300,000 units issued in its underwritten initial public offering in accordance with their terms. […]
Sensus Healthcare, Inc. Announces Separation of Units Sold in IPO
BOCA RATON, Fla., July 21, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that the 2,300,000 units issued in its underwritten initial public offering will separate in accordance with their terms […]
The SRT-100™ Beats The Keloid Scar
A quick question for you–what do you tell your patients when they come into your office and inform you that they have a keloid scar they want to get rid of? Do you offer a surgical solution that will result in them going under the knife and being stitched up? If your patient is aichmophobic, […]
SRT – The Best Keloid Scar Treatment!
SRT is the best keloid scar treatment on the market. Keloids form after the skin has been injured and the growth of fibrous tissue, more commonly known as scar tissue, begins to grow excessively. These unsightly, smooth, yet hard colonies of scar tissue are found mostly on the shoulders, cheeks, earlobes, and chest but can […]
Keloid Management: A Retrospective Case Review on a New Approach Using Surgical Excision, Platelet-Rich Plasma, and In-office Superficial Photon X-ray Radiotherapy
Michael E. Jones; Cherrell Hardy, BSN, RN; and Julie Ridgway, BSN, RN Jones Keloids Paper – July 2016 Advances in Skin & Wound Care
Provide Your Patients with an Alternative to Mohs Surgery: The SRT-100™
As a form of treatment for basal cell carcinoma and squamous cell carcinoma, Mohs surgery has lead the forefront of surgery options for decades. You may prefer Mohs surgery rather than other forms of surgery because of its precision due to its microscopic nature. However, there are no procedures without their drawbacks. You can’t put […]
Looking for an Alternative to Mohs Surgery? Look No Further than the SRT-100™
Each year millions of Americans are diagnosed with some form of squamous cell carcinoma or basal cell carcinoma. Naturally, this forces those affected to seek out forms of treatment to get rid of the cancerous cells, which are located on the outer layer of the skin. One of those types of treatments is Mohs surgery. […]
Sensus Healthcare Rings the Opening Bell at the Nasdaq MarketSite
Sensus Healthcare participated in an opening bell ringing ceremony at the Nasdaq MarketSite on Thursday, June 9, 2016. With important employees, partners and families on hand, Sensus Healthcare’s Chief Executive Officer, Joseph Sardano, officially opened the trading day on Nasdaq. This ceremony comes on the heels of the successful Initial Public Offering (IPO) of Sensus […]